A randomized, double-blind, placebo-controlled study to determine safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients

Transplant Proc. 1996 Apr;28(2):985-6.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Azathioprine / therapeutic use
  • Cyclosporine / therapeutic use
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / pharmacokinetics*
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Male
  • Middle Aged
  • Placebos
  • Polyenes / adverse effects
  • Polyenes / pharmacokinetics*
  • Polyenes / therapeutic use*
  • Prednisolone / therapeutic use
  • Sirolimus

Substances

  • Immunosuppressive Agents
  • Placebos
  • Polyenes
  • Cyclosporine
  • Prednisolone
  • Azathioprine
  • Sirolimus